Item Type | Name |
Concept
|
Skin Diseases
|
Concept
|
Skin Neoplasms
|
Concept
|
Skin
|
Academic Article
|
Pilot clinical study for quantitative spectral diagnosis of non-melanoma skin cancer.
|
Academic Article
|
Efficacy and safety of vismodegib in advanced basal-cell carcinoma.
|
Academic Article
|
Mohs surgery in metastatic cancer: renal cell carcinoma solitary cutaneous metastasis and visceral tumor metastases to skin treated with microscopically controlled surgical excision.
|
Academic Article
|
Clinical study of noninvasive in vivo melanoma and nonmelanoma skin cancers using multimodal spectral diagnosis.
|
Academic Article
|
Genomic analysis of smoothened inhibitor resistance in basal cell carcinoma.
|
Academic Article
|
Hedgehog Pathway Inhibition for Locally Advanced Periocular Basal Cell Carcinoma and Basal Cell Nevus Syndrome.
|
Academic Article
|
Pivotal ERIVANCE basal cell carcinoma (BCC) study: 12-month update of efficacy and safety of vismodegib in advanced BCC.
|
Academic Article
|
Treatment with two different doses of sonidegib in patients with locally advanced or metastatic basal cell carcinoma (BOLT): a multicentre, randomised, double-blind phase 2 trial.
|
Academic Article
|
Cross-species identification of genomic drivers of squamous cell carcinoma development across preneoplastic intermediates.
|
Academic Article
|
In vivo determination of optical properties and fluorophore characteristics of non-melanoma skin cancer
|
Academic Article
|
Safety and efficacy of vismodegib in patients with basal cell carcinoma nevus syndrome: pooled analysis of two trials.
|
Academic Article
|
The 12-month analysis from Basal Cell Carcinoma Outcomes with LDE225 Treatment (BOLT): A phase II, randomized, double-blind study of sonidegib in patients with advanced basal cell carcinoma.
|
Academic Article
|
Sonidegib for the treatment of advanced basal cell carcinoma: a comprehensive review of sonidegib and the BOLT trial with 12-month update.
|
Academic Article
|
Safety and efficacy of vismodegib in patients aged =65 years with advanced basal cell carcinoma.
|
Academic Article
|
Hedgehog pathway inhibitor therapy in basal-cell nevus syndrome.
|
Academic Article
|
Mohs Mapping Fidelity: Optimizing Orientation, Accuracy, and Tissue Identification in Mohs Surgery.
|
Academic Article
|
Burden and treatment patterns of advanced basal cell carcinoma among commercially insured patients in a United States database from 2010 to 2014.
|
Academic Article
|
Long-term safety and efficacy of vismodegib in patients with advanced basal cell carcinoma: final update of the pivotal ERIVANCE BCC study.
|
Academic Article
|
Treatment of advanced basal cell carcinoma with sonidegib: perspective from the 30-month update of the BOLT trial.
|
Academic Article
|
Emerging trends in the treatment of advanced basal cell carcinoma.
|
Academic Article
|
Surgical site identification with personal digital device: A prospective pilot study.
|
Academic Article
|
Mohs Micrographic Surgery for the Treatment of Cutaneous Metastases in a Patient With Papillary Thyroid Carcinoma.
|
Academic Article
|
PD-1 Blockade with Cemiplimab in Advanced Cutaneous Squamous-Cell Carcinoma.
|
Academic Article
|
Emerging Nonsurgical Therapies for Locally Advanced and Metastatic Nonmelanoma Skin Cancer.
|
Academic Article
|
Angiotropism in recurrent cutaneous squamous cell carcinoma: Implications for regional tumor recurrence and extravascular migratory spread.
|
Academic Article
|
Review of systemic agents in the treatment of advanced cutaneous squamous cell carcinoma.
|
Academic Article
|
Cemiplimab-rwlc as first and only treatment for advanced cutaneous squamous cell carcinoma.
|
Academic Article
|
Multiple inguinal basal cell carcinomas in the setting of intertrigo.
|
Academic Article
|
Association of Immunosuppression With Outcomes of Patients With Cutaneous Squamous Cell Carcinoma of the Head and Neck.
|
Academic Article
|
CASE (CemiplimAb-rwlc Survivorship and Epidemiology) study in advanced cutaneous squamous cell carcinoma.
|
Academic Article
|
Cemiplimab in locally advanced cutaneous squamous cell carcinoma: results from an open-label, phase 2, single-arm trial.
|
Academic Article
|
Phase 2 study of cemiplimab in patients with metastatic cutaneous squamous cell carcinoma: primary analysis of fixed-dosing, long-term outcome of weight-based dosing.
|
Academic Article
|
Inclusion of extranodal extension in the lymph node classification of cutaneous squamous cell carcinoma of the head and neck.
|
Academic Article
|
Integrating depth of invasion in T classification improves the prognostic performance of the American Joint Committee on Cancer primary tumor staging system for cutaneous squamous cell carcinoma of the head and neck.
|
Academic Article
|
Efficacy of sonidegib in histologic subtypes of advanced basal cell carcinoma: Results from the final analysis of the randomized phase 2 Basal Cell Carcinoma Outcomes With LDE225 Treatment (BOLT) trial at 42?months.
|
Academic Article
|
A Review of Hedgehog Inhibitors Sonidegib and Vismodegib for Treatment of Advanced Basal Cell Carcinoma.
|
Academic Article
|
Fixed Dose of Cemiplimab in Patients with Advanced Malignancies Based on Population Pharmacokinetic Analysis.
|
Academic Article
|
Cemiplimab in locally advanced basal cell carcinoma after hedgehog inhibitor therapy: an open-label, multi-centre, single-arm, phase 2 trial.
|
Academic Article
|
Elective neck dissection versus observation in patients with head and neck cutaneous squamous cell carcinoma.
|
Academic Article
|
Integrated analysis of a phase 2 study of cemiplimab in advanced cutaneous squamous cell carcinoma: extended follow-up of outcomes and quality of life analysis.
|
Academic Article
|
Do Not Mess With Tattoos? Mohs Micrographic Surgery for Basal Cell Carcinoma Within the State of Texas.
|
Academic Article
|
PD-1 inhibitors for cutaneous squamous cell carcinoma: A meta-analysis.
|
Academic Article
|
Use of PD-1 Inhibitors in the Treatment of Advanced Basal Cell Carcinoma.
|
Academic Article
|
Digital photography for the dermatologist.
|
Academic Article
|
Targeted Therapy and Immunotherapy in Nonmelanoma Skin Cancer.
|
Academic Article
|
Beta-Blocker Use Is Associated With Worse Relapse-Free Survival in Patients With Head and Neck Cancer.
|
Academic Article
|
Non-Melanoma Skin Cancer Detection in the Age of Advanced Technology: A Review.
|
Academic Article
|
Concomitant medication use does not appear to alter long-term efficacy of sonidegib for advanced basal cell carcinoma: a post hoc analysis based on the 42-month BOLT study.
|
Academic Article
|
Phase 2 open-label, multicenter, single-arm study of cemiplimab in patients with locally advanced basal cell carcinoma after hedgehog inhibitor therapy: Extended follow-up.
|
Academic Article
|
High response rate with extended dosing of cemiplimab in advanced cutaneous squamous cell carcinoma.
|